The estimated Net Worth of Veronica Gh Jordan is at least 381 千$ dollars as of 13 February 2017. Veronica Jordan owns over 6,695 units of Vermillion stock worth over 281,260$ and over the last 9 years he sold VRML stock worth over 0$. In addition, he makes 99,500$ as Independent Director at Vermillion.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Veronica Jordan VRML stock SEC Form 4 insiders trading
Veronica has made over 1 trades of the Vermillion stock since 2017, according to the Form 4 filled with the SEC. Most recently he bought 6,695 units of VRML stock worth 9,373$ on 13 February 2017.
The largest trade he's ever made was buying 6,695 units of Vermillion stock on 13 February 2017 worth over 9,373$. On average, Veronica trades about 446 units every 0 days since 2015. As of 13 February 2017 he still owns at least 70,315 units of Vermillion stock.
You can see the complete history of Veronica Jordan stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Veronica Jordan biography
Dr. Veronica G. H. Jordan Ph.D. is the Independent Director of the Company. Dr. Jordan became a director of Vermillion in December 2014 and serves as the Chair of our Compensation Committee and a member of our Audit Committee. Since 2007 she has served as an advisor to companies developing novel healthcare products and services. Previously, from 2001 to 2006, she was President and Chief Executive Officer of Medelle Corporation, a medical device company in women’s health. Prior to that, Dr. Jordan served for fourteen years in various executive positions at PAREXEL International Corporation. Earlier, she held business leadership roles at Biogen and managed an R&D department for Baxter International. Dr. Jordan served as a director of Albany Molecular Research Inc. (formerly Nasdaq:AMRI) from 2006 to 2016. She currently serves on the board of Bicycle Therapeutics (Nasdaq: BCYC) and is also the Chairperson for Royal Neighbors of America, a private life insurance company. In addition, Dr. Jordan currently serves on the boards of a number of not-for-profit organizations working to advance healthcare initiatives. She earned a B.Sc. in Biochemistry from Cambridge University and a Ph.D. in Biochemistry/Cell Biology from Oxford University. Dr. Jordan holds an Executive Masters Professional Director Certification from the American College of Corporate Directors.
What is the salary of Veronica Jordan?
As the Independent Director of Vermillion, the total compensation of Veronica Jordan at Vermillion is 99,500$. There are 4 executives at Vermillion getting paid more, with Valerie Palmieri having the highest compensation of 941,832$.
How old is Veronica Jordan?
Veronica Jordan is 69, he's been the Independent Director of Vermillion since 2014. There are 1 older and 5 younger executives at Vermillion. The oldest executive at Vermillion, Inc. is James Burns, 73, who is the Independent Director.
What's Veronica Jordan's mailing address?
Veronica's mailing address filed with the SEC is C/O BICYCLE THERAPEUTICS PLC, BLOCKS A & B, PORTWAY BUILDING, CAMBRIDGE, X0, CB21 6GS.
Insiders trading at Vermillion
Over the last 17 years, insiders at Vermillion have traded over 1,008,376$ worth of Vermillion stock and bought 29,557,130 units worth 34,088,488$ . The most active insiders traders include Jack W Schuler、Henri George Schuler、Larry Noracle Partners Lp F.... On average, Vermillion executives and independent directors trade stock every 59 days with the average trade being worth of 1,572,028$. The most recent stock trade was executed by Robert Harry Beechey on 15 November 2019, trading 5,000 units of VRML stock currently worth 3,550$.
What does Vermillion do?
Vermillion, Inc. engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.
What does Vermillion's logo look like?
Complete history of Veronica Jordan stock trades at Vermillion、Bicycle Therapeutics plc
Vermillion executives and stock owners
Vermillion executives and other stock owners filed with the SEC include:
-
Valerie Palmieri,
President, Chief Executive Officer, Director -
Robert Beechey,
Chief Financial Officer -
Nancy Cocozza,
Independent Director -
James LaFrance,
Independent Chairman of the Board -
Veronica Jordan,
Independent Director -
David Schreiber,
Independent Director -
James Burns,
Independent Director -
Sandra Brooks,
Independent Director -
Jack W Schuler,
-
Peter S Roddy,
Director -
Carl Severinghaus,
Director -
Larry Noracle Partners Lp O...,
-
Donald G Munroe,
SVP Business Development & CSO -
Henri George Schuler,
10% owner -
Holly B Bauzon,
VP Managed Markets -
Fred Ferrara,
Chief Information Officer -
Rajen Dalal,
Director -
Gail S Page,
President and CEO -
Qun Zhou,
Interim CFO -
Laura Ann Miller,
SVP Sales & Cust Experience -
Robert St Leger Goggin,
Director -
Ashish Kohli,
VP of Corporate Strategy -
Michael J Callaghan,
Director -
Marian E Sacco,
See Remarks -
Thomas H Mclain,
CEO & President -
James L Rathmann,
Director -
Eric Varma,
Director -
Larry Noracle Partners Lp O...,
-
John F Hamilton,
Director -
William C Wallen,
Director -
Bruce A Huebner,
Director -
William B. Creech,
VP Sales and Marketing -
Eric Schoen,
VP Finance & CAO -
Eric T Fung,
VP-Chief Science Officer -
Sandra A. Gardiner,
VP & Chief Financial Officer -
Judy Bruner,
Director -
Partners L Pwiggins James P...,
-
Diagnostics Inc Quest,
10% owner -
Kenneth J Conway,
Director -
Simon C. Shorter,
VP, Corp Business Development -
John A Young,
Director -
Larry Noracle Partners Lp F...,